Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-S&P, Nasdaq close at new highs as Wall Street rides bull momentum

Mon, 24th Aug 2020 21:20

(For a live blog on the U.S. stock market, click or
type LIVE/ in a news window.)

* Apple closes above $500 per share

* Republican National Convention begins

* Energy, financial sectors lead gains

* Indexes up: Dow 1.35%, S&P 1.00%, Nasdaq 0.60%
(Adds closing prices)

By Stephen Culp

NEW YORK, Aug 24 (Reuters) - The S&P 500 and the Nasdaq
reached new record closing highs on Monday as optimism over
potential medical advances in the war against the coronavirus
pandemic pushed all three major U.S. stock indexes higher.

The benchmark S&P 500 reclaimed its February closing high
last week, confirming a bull market and the fastest recovery
from a bear market trough on record.

The blue-chip Dow, while leading Monday's gains, remains
nearly 4.2% below its all-time high, and down 0.8% year-to-date.
The Nasdaq and the S&P have gained 26.8% and 6.2%, respectively,
since the final closing bell of 2019.

Of note, the Dow Transports index, often considered a
barometer of U.S. economic health, handily outperformed the
broader market.

"There's been a broadening in this rally and the what's
reflected in the transports," said Chuck Carlson, chief
executive officer at Horizon Investment Services in Hammond,
Indiana. "(Higher) volume is accompanying this expanding
breadth, and those are all bullish things."

Markets worldwide were given a boost by new developments in
the global race to battle the coronavirus, including an
announcement from the Food and Drug Administration that it had
given emergency authorization for the use of plasma from
recovered patients as a treatment option.

However, the World Health Organization expressed skepticism
about the treatment due to "low quality" data.

The Trump administration is considering fast-tracking an
experimental COVID-19 vaccine being developed by AstraZeneca Plc
and Oxford University in hopes it could be deployed in
the United States before Americans head to the polls in
November.

"There's an element of that news helping the 'reopening
trade,' which is a euphemism of economically sensitive stocks
performing better," Carlson added.

The four-day Republican national convention got under way on
Monday, with the party making the case for Trump's re-election.

On Capitol Hill, Democrats and Republicans remained at
loggerheads over funding levels and unemployment benefits.

Market participants will pay close attention to U.S. Federal
Reserve Chairman Jerome Powell's remarks on monetary policy at
this week's Kansas City Fed Jackson Hole symposium, which is
being held this year in a virtual format.

The Dow Jones Industrial Average rose 378.13 points,
or 1.35%, to 28,308.46, the S&P 500 gained 34.12 points,
or 1.00%, to 3,431.28 and the Nasdaq Composite added
67.92 points, or 0.6%, to 11,379.72.

Of the 11 major sectors in the S&P 500, all but healthcare
ended the session in the black.

Energy and financials enjoyed the largest
percentage gains.

Ahead of its 4-to-1 share split on Friday, Apple Inc
provided the biggest boost to the S&P 500 and the
Nasdaq, its share price closing above $500 days after becoming
the first public U.S. company to top $2 trillion in market
value. The stock gained 1.2%.

Boeing Co gave the Dow its biggest lift, rising 6.4%.

Advancing issues outnumbered declining ones on the NYSE by a
2.52-to-1 ratio; on Nasdaq, a 1.26-to-1 ratio favored advancers.

The S&P 500 posted 45 new 52-week highs and no new lows; the
Nasdaq Composite recorded 84 new highs and 36 new lows.

Volume on U.S. exchanges was 8.94 billion shares, compared
with the 9.53 billion average over the last 20 trading days.
(Reporting by Stephen Culp; Editing by Cynthia Osterman)

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.